NCT01687153

Brief Summary

Traumatic brain injury (TBI) and post traumatic stress disorder (PTSD) are common combat related problems and may be associated with a greater risk of Alzheimer's disease (AD). The purpose of this study is to examine the possible connections between TBI and PTSD, and the signs and symptoms of AD on Veterans as they age. The information collected will help to learn more about how these injuries may affect Veterans of the Vietnam War as they grow older, as well as Veterans of the current wars in Iraq and Afghanistan, who also have these types of combat related injuries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
289

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2012

Longer than P75 for all trials

Geographic Reach
1 country

19 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2012

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 18, 2012

Completed
13 days until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2021

Completed
Last Updated

November 29, 2021

Status Verified

November 1, 2021

Enrollment Period

9 years

First QC Date

August 31, 2012

Last Update Submit

November 24, 2021

Conditions

Keywords

traumatic brain injury (TBI)post traumatic stress disorder (PTSD)Alzheimer's disease (AD)mild cognitive impairment (MCI)dementiabiomarkersamyloidneuroimagingcognition disordertau

Outcome Measures

Primary Outcomes (3)

  • Rates of change in brain regions based on neuroimaging

    Rates of change in brain regions based on neuroimaging (magnetic resonance imaging \[MRI\] and amyloid positron-emission tomography \[PET\]) to show that those with TBI and/or PTSD have increased evidence for AD compared to Veteran controls

    1 year

  • Rates of change in CSF amyloid beta and CSF tau/P tau levels based on biomarkers

    Rates of change in CSF amyloid beta and CSF tau/P tau levels based on biomarkers such as cerebrospinal fluid (CSF) to show that those with TBI and/or PTSD have increased evidence for AD compared to Veteran controls

    1 year

  • Rates of change in neuropsychological measures of memory and general cognitive performance

    Rates of change in neuropsychological measures of memory and general cognitive performance based on cognitive measures to show that those with TBI and/or PTSD have increased evidence for AD compared to Veteran controls

    1 Year

Secondary Outcomes (4)

  • Correlations within each group (TBI and PTSD) to assess whether baseline levels or rates of atrophy or cognitive decline are associated with severity of TBI or PTSD

    1 year

  • Group differences in the patterns of amyloid deposition (from Florbetapir F 18) and brain atrophy

    1 year

  • Group differences in white matter integrity as assessed with Diffusion Tension Imaging (DTI)

    1 year

  • Rate of change of tau deposition as measured by 18F-AV-1451

    1 year

Study Arms (6)

Traumatic Brain Injury (TBI)

65-100 Vietnam Veterans with Traumatic Brain Injury (TBI), but without PTSD, mild cognitive impairment (MCI)/dementia

Post Traumatic Stress Disorder (PTSD)

65-100 Vietnam Veterans with PTSD, but without TBI, MCI/dementia

Controls

65-100 Vietnam Veteran Controls without TBI or PTSD and comparable in age, gender, and education to the other cohorts

TBI w/ MCI

65-100 Vietnam Veterans with TBI but without PTSD who meet the criteria for MCI but not dementia

PTSD w/ MCI

65-100 Vietnam Veterans with PTSD but without TBI who meet the criteria for MCI but not dementia

Controls w/ MCI

65-100 Vietnam Veteran Controls without TBI or PTSD who meet the criteria for MCI but not dementia, and are comparable in age, gender, and education to the other cohorts

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Vietnam Veterans

You may not qualify if:

  • General (applies to each cohort):
  • Subjects must be Veterans of the Vietnam War, 50-90 years of age. (Subjects 60-80 years of age will be selected first, while subjects \<60 or \>80 years of age will be added if recruitment numbers are too low in the 60-80 age range);
  • Must live within 150 miles of the closest ADNI clinic in subject's area.
  • Comparable in age, gender, and education with TBI and PTSD groups;
  • May be receiving Veterans Affairs (VA) disability payments for something other than TBI or PTSD - or no disability at all.
  • Subjects must have a documented history of moderate-severe non-penetrating TBI, which occurred during military service in Vietnam (identified from the Department of Defense or VA records);
  • TBI will be defined as:
  • Loss of consciousness,
  • Post-traumatic amnesia \>24 hours, OR
  • Alteration of consciousness or mental state \>24 hours
  • Subjects who meet the Structured Clinical Interview 1 of the Diagnositic and Statistical Manual of Mental Disorders, Version IV, (Axis 1) - Text Revision \[SCID-I of the DSM-IV-TR\] criteria for current/chronic PTSD (identified by records, and verified by our telephone assessments);
  • In addition to meeting DSM-IV-TR criteria for current/chronic PTSD, subjects must have a minimum current Clinician Administered PTSD Scale (CAPS) score of 50 as determined by telephone assessment;
  • The PTSD symptoms contributing to the PTSD Diagnosis and Current CAPS score must be related to a Vietnam War related trauma.
  • General (applies to each cohort):
  • MCI/dementia;
  • +16 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

Banner Sun Health Research Institute

Sun City, Arizona, 85351, United States

Location

University of California, Irvine

Irvine, California, 92697, United States

Location

University of California, San Diego

La Jolla, California, 92093, United States

Location

University of Southern California

Los Angeles, California, 90033, United States

Location

VA Palo Alto HSC / Stanford School of Medicine

Palo Alto, California, 94304, United States

Location

University of California, San Francisco

San Francisco, California, 94117, United States

Location

Georgetown University

Washington D.C., District of Columbia, 20057, United States

Location

Howard University

Washington D.C., District of Columbia, 20060, United States

Location

Wien Center for Clinical Research

Miami Beach, Florida, 33140, United States

Location

Premiere Research Institute

West Palm Beach, Florida, 33407, United States

Location

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Cornell Medical Center

New York, New York, 10021, United States

Location

Columbia University

New York, New York, 10032, United States

Location

University of Rochester Medical Center

Rochester, New York, 14620, United States

Location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Roper St Francis Healthcare

Charleston, South Carolina, 29401, United States

Location

U of WA / VA Puget Sound Alzheimer's Disease Research Center

Seattle, Washington, 98108, United States

Location

University of Wisconsin

Madison, Wisconsin, 53705, United States

Location

Related Publications (4)

  • Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005 Jul;1(1):55-66. doi: 10.1016/j.jalz.2005.06.003.

    PMID: 17476317BACKGROUND
  • Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M; Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May;6(3):202-11.e7. doi: 10.1016/j.jalz.2010.03.007.

    PMID: 20451868BACKGROUND
  • Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010 Jan;9(1):119-28. doi: 10.1016/S1474-4422(09)70299-6.

    PMID: 20083042BACKGROUND
  • Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology. 2009 Jul 28;73(4):294-301. doi: 10.1212/WNL.0b013e3181af79fb.

    PMID: 19636049BACKGROUND

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

blood, urine, cerobrospinal fluid

MeSH Terms

Conditions

Brain Injuries, TraumaticStress Disorders, Post-TraumaticAlzheimer DiseaseCognitive DysfunctionDementiaCognition DisordersPick Disease of the Brain

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesStress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersFrontotemporal DementiaFrontotemporal Lobar Degeneration

Study Officials

  • Michael W. Weiner, MD

    University of California, San Francisco

    STUDY DIRECTOR
  • Paul Aisen, MD

    USC Alzheimer's Therapeutic Research Institute (ATRI)

    PRINCIPAL INVESTIGATOR
  • Ronald Petersen, MD, PhD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 31, 2012

First Posted

September 18, 2012

Study Start

October 1, 2012

Primary Completion

September 21, 2021

Study Completion

September 21, 2021

Last Updated

November 29, 2021

Record last verified: 2021-11

Locations